Zeng, Kangmei
36  results:
Search for persons X
?
3

The BCL-2 inhibitor APG-2575 resets tumor-associated macrop..:

Luo, Fan ; Li, Han ; Ma, Wenjuan...
Cellular & Molecular Immunology.  21 (2023)  1 - p. 60-79 , 2023
 
?
 
?
 
?
10

Anticancer bispecific antibody R&D advances: a study focusi..:

Zhang, Zhonghan ; Luo, Fan ; Cao, Jiaxin...
Journal of Hematology & Oncology.  14 (2021)  1 - p. , 2021
 
?
 
?
12

Pemetrexed/carboplatin plus gefitinib as a first-line treat..:

Zhang, Zhonghan ; Zeng, Kangmei ; Zhao, Shen...
Therapeutic Advances in Medical Oncology.  11 (2019)  - p. 175883591989165 , 2019
 
?
13

The BCL-2 inhibitor APG-2575 resets tumor-associated macrop..:

Luo, Fan ; Li, Han ; Ma, Wenjuan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10757718/.  , 2023
 
?
14

Correction to: Lymphocyte activating gene 3 protein express..:

Luo, Fan ; Cao, Jiaxin ; Lu, Feiteng...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801109/.  , 2022
 
?
15

Anticancer bispecific antibody R&D advances: a study focusi..:

Zhang, Zhonghan ; Luo, Fan ; Cao, Jiaxin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369643/.  , 2021
 
1-15